{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:15:42Z","timestamp":1780416942680,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10067-018-4145-8","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T21:38:31Z","timestamp":1526420311000},"page":"2007-2009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Resolution of femoral metaphyseal dysplasia in CINCA syndrome after long-term treatment with interleukin-1 blockade"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-7779","authenticated-orcid":false,"given":"Donato","family":"Rigante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Verrecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Marrocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"4145_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/1744666X.2017.1280396","volume":"13","author":"D Rigante","year":"2017","unstructured":"Rigante D (2017) A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner. Expert Rev Clin Immunol 13:571\u2013597","journal-title":"Expert Rev Clin Immunol"},{"key":"4145_CR2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1177\/039463201102400402","volume":"24","author":"L Cantarini","year":"2011","unstructured":"Cantarini L, Lucherini OM, Frediani B, Brizi MG, Bartolomei B, Cimaz R, Galeazzi M, Rigante D (2011) Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes. Int J Immunopathol Pharmacol 24:827\u2013836","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4145_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/21678707.2018.1406797","volume":"6","author":"D Rigante","year":"2018","unstructured":"Rigante D (2018) A developing portrait of hereditary periodic fevers in childhood. Expert Opin Orphan Drugs 6:47\u201355","journal-title":"Expert Opin Orphan Drugs"},{"key":"4145_CR4","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.autrev.2014.08.001","volume":"13","author":"D Rigante","year":"2014","unstructured":"Rigante D, Vitale A, Lucherini OM, Cantarini L (2014) The hereditary autoinflammatory disorders uncovered. Autoimmun Rev 13:892\u2013900","journal-title":"Autoimmun Rev"},{"key":"4145_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.imlet.2017.11.013","volume":"193","author":"D Rigante","year":"2018","unstructured":"Rigante D (2018) New mosaic tiles in childhood hereditary autoinflammatory disorders. Immunol Lett 193:67\u201376","journal-title":"Immunol Lett"},{"key":"4145_CR6","doi-asserted-by":"publisher","first-page":"194864","DOI":"10.1155\/2015\/194864","volume":"2015","author":"G Lopalco","year":"2015","unstructured":"Lopalco G, Cantarini L, Vitale A et al (2015) Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Mediat Inflamm 2015:194864","journal-title":"Mediat Inflamm"},{"key":"4145_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/03009740310003974","volume":"32","author":"G Federico","year":"2003","unstructured":"Federico G, Rigante D, Pugliese AL, Ranno O, Catania S, Stabile A (2003) Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome. Scand J Rheumatol 32:312\u2013314","journal-title":"Scand J Rheumatol"},{"key":"4145_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00381-006-1280-3","volume":"22","author":"D Rigante","year":"2006","unstructured":"Rigante D, Ansuini V, Caldarelli M, Bertoni B, La Torraca I, Stabile A (2006) Hydrocephalus in CINCA syndrome treated with anakinra. Childs Nerv Syst 22:334\u2013337","journal-title":"Childs Nerv Syst"},{"key":"4145_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00296-009-0939-y","volume":"30","author":"D Rigante","year":"2010","unstructured":"Rigante D, Stabile A, Minnella A, Avallone L, Ziccardi L, Bersani G, Stifano G, Compagnone A, Falsini B (2010) Post-inflammatory retinal dystrophy in CINCA syndrome. Rheumatol Int 30:389\u2013393","journal-title":"Rheumatol Int"},{"key":"4145_CR10","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/1756-185X.12800","volume":"19","author":"D Rigante","year":"2016","unstructured":"Rigante D, Verrecchia E, Falsini B, Manna R (2016) Switch from anakinra to canakinumab in a severe case of CINCA syndrome. Int J Rheum Dis 19:1354\u20131356","journal-title":"Int J Rheum Dis"},{"key":"4145_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/039463201102400315","volume":"24","author":"L Cantarini","year":"2011","unstructured":"Cantarini L, Iacoponi F, Lucherini OM, Obici L, Brizi MG, Cimaz R, Rigante D, Benucci M, Sebastiani GD, Brucato A, Sabadini L, Simonini G, Giani T, Pasini FL, Baldari CT, Bellisai F, Valentini G, Bombardieri S, Paolazzi G, Galeazzi M (2011) Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults. Int J Immunopathol Pharmacol 24:695\u2013702","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4145_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1136\/annrheumdis-2016-210092","volume":"76","author":"NM Haar ter","year":"2017","unstructured":"ter Haar NM, Annink KV, Al-Mayouf SM et al (2017) Development of the autoinflammatory disease damage index (ADDI). Ann Rheum Dis 76:821\u2013830","journal-title":"Ann Rheum Dis"},{"key":"4145_CR13","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/art.22491","volume":"56","author":"I Aksentijevich","year":"2007","unstructured":"Aksentijevich I, Putnam CD, Remmers EF et al (2007) The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum 56:1273\u20131285","journal-title":"Arthritis Rheum"},{"key":"4145_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1546-0096-8-9","volume":"8","author":"T Miyamae","year":"2010","unstructured":"Miyamae T, Inaba Y, Nishimura G, Kikuchi M, Kishi T, Hara R, Kaneko U, Shinoki T, Imagawa T, Yokokta S (2010) Effect of anakinra on arthropathy in CINCA\/NOMID syndrome. Pediatr Rheumatol Online J 8:9","journal-title":"Pediatr Rheumatol Online J"},{"key":"4145_CR15","first-page":"45","volume":"37","author":"SC Hill","year":"2007","unstructured":"Hill SC, Namde M, Dwyer A, Poznanski A, Canna S, Goldbach-Mansky R (2007) Arthropathy of neonatal onset multisystem inflammatory disease (NOMID\/CINCA). Pediatr Radiol 37:45\u201352","journal-title":"Pediatr Radiol"},{"key":"4145_CR16","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1586\/1744666X.2015.1077702","volume":"11","author":"I Kon\u00e9-Paut","year":"2015","unstructured":"Kon\u00e9-Paut I, Galeotti C (2015) Current treatment recommendations for cryopyrin-associated periodic syndrome. Expert Rev Clin Immunol 11:1083\u20131092","journal-title":"Expert Rev Clin Immunol"},{"key":"4145_CR17","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1093\/rheumatology\/kew208","volume":"55","author":"T Kullenberg","year":"2016","unstructured":"Kullenberg T, L\u00f6fqvist M, Leinonen M, Goldbach-Mansky R, Olivecrona H (2016) Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes. Rheumatology (Oxford) 55:1499\u20131506","journal-title":"Rheumatology (Oxford)"},{"key":"4145_CR18","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1136\/annrheumdis-2013-204877","volume":"74","author":"CH Sibley","year":"2015","unstructured":"Sibley CH, Chioato A, Felix S, Colin L, Chakraborty A, Plass N, Rodriguez-Smith J, Brewer C, King K, Zalewski C, Kim HJ, Bishop R, Abrams K, Stone D, Chapelle D, Kost B, Snyder C, Butman JA, Wesley R, Goldbach-Mansky R (2015) A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease. Ann Rheum Dis 74:1714\u20131719","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4145-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T21:27:49Z","timestamp":1557955669000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4145-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4145"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4145-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]},"assertion":[{"value":"28 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"A formal written informed consent was released by both patient\u2019s parents and patient himself for the publication of this case based review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}